NEW YORK (Reuters Health) – Cumulative exposure to particular antiretroviral agents in patients being treated for HIV infection is associated with an increased risk of developing chronic kidney…
NEW YORK (Reuters Health) – The notable accumulation of visceral fat that occurs in some patients with HIV who are on antiretroviral drugs can be reduced substantially by…
NEW YORK (Reuters Health) – The adverse effects of conventional amphotericin B for treating acute cryptococcal meningitis in AIDS patients can be reduced significantly by using the liposomal…
NEW YORK (Reuters Health) – High-grade anal dysplasia is prevalent in HIV-positive gay men and high-resolution anoscopy is the best way to detect it, clinicians from Canada have…
NEW YORK (Reuters Health) – Pegylated interferon alfa-2a safely reduces HIV-1 load in untreated patients without chronic hepatitis C virus (HCV) infection, according to a report in the…
NEW YORK (Reuters Health) – Tenofovir nephrotoxicity can’t always be fully reversed in HIV-infected men, according to a new study. Up to 2% of patients have adverse renal…
NEW YORK (Reuters Health) – In patients with HIV and tuberculosis (TB) whose CD4 cell counts are below 500/mm3, mortality is increased if antiretroviral therapy is delayed until…
NEW YORK (Reuters Health) – The nucleoside reverse transcriptase inhibitors (NRTIs) abacavir and didanosine, and the protease inhibitors (PIs) indinavir and lopinavir-ritonavir, all increase the risk of myocardial…
NEW YORK (Reuters Health) – In HIV-infected patients, risk factors for thrombocytopenia include interruptions in antiretroviral therapy, high HIV RNA levels, hepatitis C virus (HCV) infection, and cirrhosis,…
NEW YORK (Reuters Health) – Genital ulcers are common in HIV-infected women when antiretroviral therapy (ART) begins, particularly when CD4 counts are low or when women have had…